Rest Of Europe Infectious Disease Diagnostics Market (2025-2030)
The Rest Of Europe Infectious Disease Diagnostics Market was valued at $551.6 Million in 2025 and projected to reach to $798.9 Million by 2030, representing a compound annual growth rate of 7.7%. Rest of Europe's infectious disease diagnostics market demonstrates consistent growth momentum, supported by expanding healthcare budgets and modernization of laboratory facilities across the region.
Rest Of Europe Infectious Disease Diagnostics Market Trends and Insights
- In Middle East & Africa, rising disease burden, improving healthcare infrastructure, and increased investment in diagnostic capabilities are driving market expansion.
- The region's growing focus on early disease detection and pandemic preparedness is accelerating adoption of advanced diagnostic technologies across hospitals, clinics, and laboratories. Middle East & Africa is experiencing significant demand for rapid and accurate infectious disease testing solutions, supported by government health initiatives and international partnerships.
- In Middle East & Africa, the market is characterized by a mix of established diagnostic providers and emerging local players competing to capture growing demand.
- The forecast period through 2030 reflects sustained momentum in Middle East & Africa as healthcare systems prioritize infectious disease surveillance and point-of-care testing capabilities..
Key Market Statistics
- CAGR (2025-2030) 7.7% CAGR
- Market Size, 2025 ~USD 551.6 Million
- Forecast, 2030 ~USD 798.9 Million
- Country Rest Of Europe
Rest Of Europe Infectious Disease Diagnostics Market Overview
Market Valuation :
Rest of Europe's infectious disease diagnostics market is valued at USD 551.6 million in 2025, with steady growth trajectory driven by regional healthcare modernization initiatives.
Growth Trajectory :
The market is projected to reach USD 798.9 million by 2030, representing a 7.7% CAGR, reflecting robust demand for advanced diagnostic solutions across secondary and tertiary healthcare facilities.
Healthcare Infrastructure Development :
Increasing investments in diagnostic infrastructure across Rest of Europe countries are accelerating adoption of molecular and immunological testing platforms for infectious disease detection.
Regional Disease Burden :
Rising prevalence of communicable diseases and strengthened disease surveillance programs in Rest of Europe are creating sustained demand for rapid, accurate diagnostic technologies.
Rest Of Europe Infectious Disease Diagnostics Market Dynamics
- The 7.7% CAGR reflects increasing adoption of point-of-care testing and molecular diagnostics in both urban and emerging healthcare centers. Key growth drivers include enhanced disease surveillance networks, regulatory support for diagnostic innovation, and rising awareness of early disease detection benefits.
- Strategic partnerships between diagnostic manufacturers and regional healthcare providers are expected to accelerate market penetration, particularly in molecular and rapid testing segments, positioning Rest of Europe as a significant growth market within the broader European diagnostic landscape..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- Middle East & Africa infectious disease diagnostics market valued at USD 551.6 million in 2025, expanding to USD 798.9 million by 2030
- Middle East & Africa market growing at 7.7% CAGR, driven by rising disease prevalence and healthcare infrastructure investment
- Middle East & Africa demand for rapid diagnostics and point-of-care testing accelerating across public and private healthcare facilities
- Middle East & Africa competitive landscape includes both multinational diagnostic leaders and emerging regional players capturing market share
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
Rest Of Europe Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Device Manufacturers : Need regional market data to develop targeted product strategies, identify distribution partnerships, and optimize commercial operations across Rest of Europe's diverse healthcare markets.
- Healthcare System Administrators : Require market insights to inform procurement decisions, budget planning, and diagnostic capability development aligned with regional disease burden and healthcare priorities.
- Investment & Private Equity Firms : Seek comprehensive market analysis to evaluate investment opportunities in diagnostic companies and healthcare infrastructure projects with growth potential in Rest of Europe.
- Clinical Laboratory Operators : Need market forecasts and competitive intelligence to guide service expansion, technology adoption, and strategic positioning within Rest of Europe's diagnostic testing landscape.
- Healthcare Consultants & Advisors : Require detailed regional market data to support client advisory services, feasibility studies, and strategic planning initiatives focused on infectious disease diagnostics in Rest of Europe.
Key Companies in the Rest Of Europe Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Regional Market Sizing : Obtain precise market valuation and forecasting data specific to Rest of Europe, enabling accurate budget allocation and regional expansion planning for diagnostic product portfolios.
- Growth Opportunity Identification : Identify high-potential segments and geographic sub-regions within Rest of Europe experiencing accelerated adoption of infectious disease diagnostics through detailed market segmentation analysis.
- Competitive Landscape Intelligence : Understand regional competitive dynamics, market share distribution, and strategic positioning of key diagnostic manufacturers operating in Rest of Europe's healthcare ecosystem.
- Healthcare Infrastructure Insights : Gain actionable intelligence on diagnostic infrastructure development, regulatory environment, and reimbursement trends shaping market opportunities across Rest of Europe countries.
- Strategic Decision Support : Leverage comprehensive market data to support go-to-market strategies, partnership development, and investment decisions for infectious disease diagnostic solutions in Rest of Europe.
Frequently asked questions
What is the current market size of infectious disease diagnostics in Middle East & Africa?
The Middle East & Africa infectious disease diagnostics market is valued at USD 551.6 million in 2025.
What is the projected market size for Middle East & Africa by 2030?
The Middle East & Africa infectious disease diagnostics market is projected to reach USD 798.9 million by 2030.
What is the growth rate for infectious disease diagnostics in Middle East & Africa?
The Middle East & Africa market is expected to grow at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.
What factors are driving growth in the Middle East & Africa infectious disease diagnostics market?
Key drivers in Middle East & Africa include rising infectious disease burden, improved healthcare infrastructure, government health initiatives, pandemic preparedness efforts, and increased adoption of point-of-care testing technologies.
Who are the main competitors in the Middle East & Africa infectious disease diagnostics market?
The Middle East & Africa market includes multinational diagnostic companies and emerging regional players competing across hospitals, clinics, and laboratory settings.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report